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Sebastian Bao Dinh Bui and Parisa Gazerani*Abstract
Background: Headache attributed to airplane travel, also named "airplane headache" (AH) is a headache that
occurs during take-off and landing. Today, there are still uncertainties about the pathophysiology and treatment of
AH. This systematic review was performed to facilitate identification of the existing literature on AH in order to
discuss the current evidence and areas that remain to be investigated in AH.
Methods: The systematic literature search was performed in 3 relevant medical databases; PubMed, Scopus, and
Embase. The search yielded 220 papers and the papers were sorted based on inclusion and exclusion criteria
established for this study.
Results: This systematic review included 39 papers. Main findings revealed that AH attacks are clinically stereotyped
and appear mostly during landing phases. The headache presents as a severe painful headache that often
disappears within 30 min. The pain is unilateral and localized in the fronto-orbital region. Sinus barotrauma has
been considered as the main cause of AH. Nonsteroidal anti-inflammatory drugs and triptans have been taken by
passengers with AH, to relieve the headache.
Conclusions: Based on this systematic review, further studies seem required to investigate underlying mechanisms
in AH and also to investigate the biological effects of nonsteroidal anti-inflammatory drugs and triptans for
alleviating of AH. These studies would advance our understanding of AH pathogenesis and potential use of
treatments that are not yet established.
Keywords: Headache attributed to airplane travel, Airplane headache, Diagnosis, Pathophysiology, Treatment, Sinus
barotrauma, NSAIDs, TriptansIntroduction
Headache attributed to airplane travel, also named "air-
plane headache" (AH) occurs in a population of passen-
gers during airplane travels. The headache appears as an
intense short lasting pain at landing and it is often lo-
cated in the fronto-orbital region [1–7]. Despite its oc-
currence rate and high impact, only limited is known
about AH, and this type of headache has only been de-
fined and included in the headache classification since
2013 by International Headache Society (IHS), which
provides headache classifications and maintains related
updates [1]. The first case of AH was described in 2004,* Correspondence: gazerani@hst.aau.dk
SMI®, Department of Health Science and Technology, Faculty of Medicine,
Aalborg University, Aalborg, Denmark
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the Creative Commons license, and indicate ifand since then, number of publications on AH has been
added into the literature [2–25]. Previous reports, before
inclusion of AH in classification, could be based on diver-
sity in diagnosis, which makes it difficult to determine
whether reported patients suffered from AH or other con-
ditions [1, 6]. Despite the fact that some points are known
based on these publications, there is still uncertainty
around influence of ethnicity, gender or age on incidence
or prevalence of AH. A male dominancy has been re-
ported for AH [4, 6, 26]. Current knowledge about patho-
physiology and treatment of AH is limited that calls for
further investigation on both epidemiological aspects of
AH, pathophysiology and treatment options.
There is also a diverse range of hypotheses about the
pathophysiological causes of AH. Previous studies haveis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
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barotrauma as a result of cabin pressure change in the
airplane [2, 3, 6, 11, 12, 26]. These proposed mechanisms
require further investigation to prove or falsify suggested
theories. Besides, no specific treatment plan has been
developed for AH, although several medications have
shown beneficial effects, e.g. triptans [11]. Considering
challenges and limitation of AH studies under real-time
conditions, it might be an option to study this headache
under controlled experimental conditions. This approach
has also been used in studying other types of headaches
[25]. An experimental model of AH has been developed
recently [25] that can help in further understanding of
potential mechanisms underlying AH, or to examine AH
under different circumstances, and identification of poten-
tial biological biomarkers. This model [25] can also serve
for testing treatment options for AH.
To provide a better overview of existing literature on
diagnosis, pathophysiology, and treatment of AH, this
systematic review was performed. It was proposed that
outcome of this review would highlight existing evidences,
missing information, and stimulate further research in
AH. Understanding AH pathogenesis and efficient target-
ing would ultimately help millions of passengers who
suffer from this condition.Methods
Literature search
Both authors (SBDB and PG) contributed in performing
the systematic literature search in PubMed, Scopus, and
Embase by using the terms “airplane headache” and
“aeroplane headache” (airplane OR aeroplane AND
headache). PubMed was searched on 2nd March 2017
(January 2004 to March 2017), Scopus was searched on
3rd March 2017 (January 2004 to March 2017) and
Embase was searched on 5th March 2017 (January 2004
to March 2017).Selection criteria and data extraction
Due to limited information available about AH, all types
of studies and levels of evidence about AH were consid-
ered eligible for inclusion, including i.e. case series, case
reports, conference abstracts, and all types of publications
providing knowledge on diagnosis, pathophysiology, or
treatment of AH. All papers were exported and duplicates
were excluded through the Excel 2010 (Microsoft Corp.,
Seattle, WA, USA). Titles that appeared relevant were
assessed for inclusion. Papers were excluded if they were
not available in English. All data from the included papers
were reviewed and tabulated according to authors of
study, year, study type, demographic data on the patients,
and main outcomes.Results
Literature search
The flowchart for selection of papers is shown in Fig. 1.
The search strategy identified 220 papers. The authors
excluded 175 papers due to lack of relevance to AH.
Furthermore, 6 additional papers were excluded as those
did not contain relevant description of AH, were not
written in English, and reported the same data from an
existing case report on AH. The authors, therefore, in-
cluded 39 papers for the final review, which provided suffi-
cient information on diagnosis, pathophysiology and/or
treatment of AH (see Table 1).
AH diagnosis
The clinical diagnostic data are presented as cumulative
from all included papers (Table 1) [2–40]. In this cumu-
lative synthesis, 275 patients are represented [2, 4–13,
15–19, 21, 25–28, 31, 33–37, 39, 40]; 127 females (46%)
and 148 males (54%). The median age at diagnosis was
28.7 ± 4.8 (mean ± SD) years (n = 275/275) and the
median age of onset of the first AH-attack was 26.4 ± 3.8
(mean ± SD) years (reported by 163/275 patients).
Duration, severity and frequency of AH
Collectively, based on available evidences, landing appears
to be the phase of the flight during which most of patients
experience AH-attack with a duration within 30 min.
During the AH-attack, the pain is described as severe with
a rating of 8–10 on a scale from 0 (no pain) to 10 (worst
possible pain), (n = 229/275). In few cases, patients have
had experienced a second mild phase headache after the
AH-attack that resolved within 4–24 h (n = 2/275). The
frequencies of the AH-attacks were reported by some pa-
tients: 42 patients experienced AH in every flight travel,
while AH occurred in more than 50% of the flight travels
in 39 patients.
Symptoms characteristics of AH
The AH-attack is often experienced as jabbing, stabbing
and/or pulsating in the unilateral fronto-orbital region
and is not associated with accompanying symptoms in
most of the AH-attacks. However, few patients did
experience these accompanying symptoms; dizziness
(n = 2/275), sensation of paraesthesias starting from the
left thumb accompanied by spread to the hand and
perioral region (n = 1/275).
Medical history
The majority of the AH-patients did not have any relevant
medical history. However, some patients had a history of
migraine (n = 54/275), tension type headache (n = 22/
275), allergy (n = 25/275), and chronic non-allergic rhino-
sinusitis (n = 1/275). A minority of patients reported that
they also suffered from High Altitude Headache (n = 13/
Fig. 1 PRISMA flowchart for the selection of studies
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Scuba Diving Headache (n = 9/275).
Neurological examinations
Neurological examinations, such as brain magnetic reson-
ance imagining (MRI), magnetic resonance angiography
(MRA), ear-nose-throat (ENT) and/or computerized tom-
ography (CT) were performed in 46 patients. MRI, MRA,
ENT and CT showed normal findings in the majority of
the AH-patients (n = 38/46), but a small patient group
(n = 8/46) showed inflammation and thickening of the
mucosal wall in the sinuses observed in MRI (n = 4/8),
MRA (n = 1/8), and CT (n = 7/8).
AH pathophysiology
The pathophysiology of AH is still unknown, but specula-
tive hypotheses have been proposed. The most frequently
discussed mechanism for AH is that the changes in the
cabin pressure during take-off and landing may lead to
sinus barotrauma, local inflammation, and thereby devel-
opment of AH [2–7, 9–14, 18–21, 24–27, 32, 35, 39, 40].Due to possible variations in the anatomical and structural
construction in the individual ethmoid sinuses, including
ethmoid cells, these patients cannot equalize the pressure
during the take-off or landing [7]. Ethmoid cells are
innervated by branches of the trigeminal nerve, where
these nerve endings may trigger a stimulus as a conse-
quence of sinus barotrauma and thereby inflammation
due to the lack of pressure equalization [7]. This may
lead to the characteristic of pain localized in the
fronto-orbital region [7].
So far, there has been only one experimental study that
has attempted to investigate the mechanism in AH [25].
Prostaglandin E2 (PGE2) has been shown to be signifi-
cantly high in AH-patients during a simulated flight
when compared with healthy subjects. It is speculated
that PGE2 is elevated due to local inflammation, which
may cause vasodilation in the cerebral arteries and induce
AH [25]. Based on one case occurred during landing,
reversible cerebral vasoconstriction syndrome (RCVS) has
been advanced as a possible mechanism in the patho-
physiology of AH [23].
Table 1 Demographic characteristics and main outcomes of the current literature regarding headache attributed to airplane travel
Year, Author (reference) Number of
AH-patients
Gender (number
of M/F)
Mean diagnosis age
(mean ± SD) years
Publication
type
Main outcomes
2004, Atkinson et al. [8] 1 1 M 28 Case report • Patient developed a severe headache during ascent and
descent. The pain was described as jabbing in the
unilateral fronto-orbital region and lasted within 20 min.
• Patient had no relevant medical history, used no
medication and had no symptoms of sinus disease.
• Neurological examinations were performed, CT and MRI,
with normal findings.
2006, Berilgen et al. [7] 6 6 M 37.3 ± 2.9 Case reports • All 6 patients experienced a severe headache when the
airplane was taking off or landing. The pain was
described as jabbing and stabbing in the orbital and/or
supraorbital region. The headaches resolved within 15–
20 min.
• Three patients reported a history of migraine without
aura, retinal migraine and exercise headache.
• The authors suggested sinus barotrauma as the main cause
of the headache. The pressure changes during the ascent
and descent would potentially activate the trigeminovascular
system and thereby induce the headache attack.
• Examinations of neurological, ENT, blood analyses, MRI
and paranasal sinus tomography showed normal
findings.
2007, Evans et al. [9] 4 2 M/2 F 26.8 ± 3.9 Case reports • All patients developed severe headache during the
descent that lasted about 15–30 min. The pain intensity
was rated as 10/10 and located in parietal and ethmoid
regions.
• Two patients experienced a second mild/moderate
headache after the AH.
• Ibuprofen was used by two patients; one patient
experienced a mild reduction in pain and one did not
experience any relieving effect.
• The authors stated that sinus barotraume might be an
explanation for the cause of the AH.
• Examinations of CT, MRI and ENT showed normal findings.
2007, Mainardi et al. [5] 1 1 M 23 Case report • The patient developed a severe pulsating headache after
the take-off in the retro-orbital and frontal region. The
headache lasted about 10–15 min.
• Patient had no relevant medical history.
• Authors believed that sinus barotrauma might not explain
the cause of the headache as this patient developed the
headache after the take-off.
• Neurological and neuroradiological examinations (MRI
and MRA) showed normal findings.
2008, Marchioretto et al. [15] 1 1 M 29 Letter to the
editor
• The patient developed a highly sharp intense headache
pain during the landing in the periorbital region. The
pain resolved after 5 min.
• Sodium naproxen 550 mg, one tablet, was taken by the
patient after the first incidence of headache. He did not
experience any headache after the use of the medication.
• Neuroradiological examinations (MRI and MRA) showed
normal findings.
2008, Coutinho et al. [17] 1 1 M 57 Case report • The patient always developed an intense headache pain in
the left frontal region during the landing. The headache
often lasted between 5 and 10 min.
• There was no relevant medical history and no history of
sinus pathology.
• Neurological examination, ENT and MRI, showed normal
findings.
• The authors excluded sinus barotrauma as a possible
explanation of the headache due to the normal findings
of the MRI.
2008, Potasman et al. [4] 52 18 M/34 F 33.3 ± 13.8 Journal article • The travelers developed headache during the ascent and
descent. The pain was often described as a unilateral or
bilateral pressuring sensation with a pain intensity of 6
(on a scale of 1–10).
• The headache lasted 4.0 h after take-off and 5.7 h after
landing.
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Table 1 Demographic characteristics and main outcomes of the current literature regarding headache attributed to airplane travel
(Continued)
• In the headache group, 23 passengers were diagnosed
with migraine, 3 passengers reported sinusitis as the
cause of the headache and 3 passengers reported
hypertension as the cause.
• Medications such as paracetamol, dipyrone and triptans,
were taken by 25 travelers. The effects were not reported.
2008, Kim et al. [27] 1 1 M 38 Case report • The patient developed a severe headache during the
landing. The pain was described as jabbing and located
in the supraorbital area. The headache lasted about
30 min.
• Neurological examinations, x-ray of paranasal sinuses and
cranial CT showed overall normal findings, except for
mucosal thickening of the right ethmoid sinus.
• Authors stated that the results of the thickening ethmoid
sinus mucosa might be an incidental finding.
2010, Baldacci et al. [13] 1 1 F 20 Case report • The patient experienced a sharp pain in the right retro-
orbital and frontal regions during the take-offs. The pain
sensation was severe with the rating 10/10 and the
headache disappeared within 10 min.
• There was no relevant medical history; but, every
headache attack was preceded with a characteristic
sensory aura. She always experienced a sensation of
paraesthesias starting from the left thumb accompanied
by spread to her hand and to the perioral region. These
symptoms lasted 5–10 min before the start of the
headache attack.
• Neurological examinations, ENT, EEG, CT and MRA showed
normal findings.
• The authors stated that sinus barotrauma might explain
the mechanism for the headache and suggest that the
reported aura might be related to the pressure changes
in the cabin.
2010, Domitrz [10] 1 1 M 29 Case report • The patient developed a sudden jabbing headache
during the take-off and landing – but only when he was
travelling with airplane and not with jumbo jet. The pain
was located in the left frontal region with radiation into
the left eye. The intensity of the pain was severe and the
patient could not move until the headache disappeared.
• Medical history was not relevant. Neurological-,
ophtolaryngological-, and ophthalmological
examinations and MRA showed normal findings.
• The author stated that sinus barotrauma might be a
possible cause of the headache.
2010, Ipekdal et al. [28] 2 1 M/ 1 F 12 ± 1 Conference
abstract
• Two children suffered from severe headaches during the
landing phase.
• Blood sample analyses, cerebral MRI and MRA showed
normal findings. However, paranasal sinus tomography
revealed pansinusitis in the male patient and bilateral
maxillary sinusitis in the female patient.
• Both patients were given antibiotic and anti-inflammatory
medications and experienced afterwards headache-free
airplane travels.
2010, Ipekdal et al. [16] 3 1 M/ 2 F 13 ± 0.8 Case reports • Three children developed severe headaches during the
ascent and descent. The pain was located in the unilateral
periorbital and orbito-frontal region and lasted between 10
and 25 min.
• One patient had a history of allergy rhinitis and allergy
to pollens.
• Paranasal sinus tomography and MRI showed nasal
mucosal wall thickening and inflammation in all 3
patients. ENT showed adenoidal and tonsillar
hypertrophy in one patient.
• The patient with adenoidal and tonsillar hypertrophy
underwent adenotonsillectomy surgery and experienced
headache-free airplane travels after recovery.
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Table 1 Demographic characteristics and main outcomes of the current literature regarding headache attributed to airplane travel
(Continued)
• The 2 other patients with inflamed nasal mucosal walls were
given antihistamine and anti-inflammatory medications and
were completely headache-free after treatment.
• The authors stated that their effective treatment with
antihistamine and anti-inflammatory medications support
the theory that sinus barotrauma plays a central role in
the mechanism of AH.
2010, Pfund et al. [19] 1 1 F 27 Case report • The patient developed bilateral headache located in her
ear, cheek, forehead, and on the top of the head. The pain
was described as stabbing, jabbing and rated as 10/10.
• The severe headache pain disappeared after landing, but
was followed by a mild headache that lasted two weeks
after the flight travel.
• MRI and paranasal sinus computed tomography and
revealed bilateral inflammation in the sphenoid,
maxillary and ethmoid sinuses. Furthermore, the patient
had increased number of eosinophilic cells and swelled
nasal mucosa. These findings supported the diagnosis
of chronic non-allergic rhinosinusitis.
• Patient was given antihistamine and experienced almost
painless airplane travels.
• The authors supported the sinus barotrauma as a central
role in the mechanism of AH.
2011, Berilgen et al. [26] 18 16 M/ 2 F 34.25 ± 7.7 Case reports • All patients developed a severe headache during the
landing phase. The pain was located in the frontal and
orbital region and described as jabbing and stabbing
with a duration of 15–30 min.
• All ENT and neurological examinations showed normal
findings.
• The authors supported the hypothesis of sinus barotrauma
as a possible mechanism of AH.
2011, Mainardi et al. [29] N/A N/A N/A Letter to the
editor
• The authors stated that the findings from the paper by
Pfund et al. [19] differ from the stereotypical AH-attacks:
1) The AH-attack does not exceed 30 min, 2) the pain is
not strictly bilateral and 3) neuroradiological examina-
tions do not show signs of sinus inflammation.
• They suggested that “pure” AH should be considered as
a separated headache from the flight-related headache
in patients with organic condition.
2011, Ipekdal et al. [11] 5 1 M/ 4 F 29.6 ± 1.9 Case reports • All the patients developed a severe headache during the
ascending or the descending phase. The pain was
located in the unilateral fronto-orbital region and lasted
between 15 and 25 min.
• Triptans were prescribed to all patients and they were
instructed to take a triptan (either naratriptan, zolmitriptan,
eletriptan or sumatriptan) 30 min before the start of the
airplane travel. There was a follow-up period of 2–4 years
and all patients were completely headache-free in all their
airplane travels.
• The authors indicated that sinus barotrauma might play
a role in the mechanism of AH. They also hypothesized
that the use of triptans may cause vasospasm in cerebral
arteries and thereby prevent the AH-attack.
2011, Mainardi et al. [30] N/A N/A N/A Letter to the
editor
• The authors suggested that AH should be included in the
forthcoming revision of the “International Classification of
Headache Disorders” in the section of “Headache attributed
to disorder of homoeostasis”.
• They stated that the criteria set by Berilgen et al. [26] are
broadened. The criteria of AH should be restrictive and
clearly defined in order to properly diagnose the
headache.
2011, Mainardi et al. [31] 63 41 M/ 22 F 29.5 Conference
abstract
• The headache occurred mainly at landing and in the
fronto-orbital region. Pain intensity was severe and lasted
about 20 min.
• Prophylactic use of NSAIDs prevented the AH-attacks.
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(Continued)
• The authors stated that their findings confirm the
stereotypical features of AH and that the headache
should be recognized by The International Headache
Society.
2011, Kararizou et al. [12] 1 1 F 27 Case report • The patient experienced an intense headache in the
frontotemporal and retro-orbital area of the skull. The pain
was described as jabbing and lasted about 15–20 min.
• She had a history of tension type headache. ENT, CT,
MRI and MRA showed normal findings. A test for anxiety
and depression was performed with a score of 14 on the
Hamilton anxiety scale (mild anxiety ≥14) and 12 on the
Hamilton depression scale (mild depression >7).
• Paracetamol and ibuprofen were taken by the patient,
but there was no relieving effect.
• The authors stated that psychiatric disorders should be
investigated for future studies in order to establish a possible
signification to AH. This might clarify the mechanism of AH
and specify effective therapeutic strategies.
2012, Mohamad [24] N/A N/A N/A Letter to the
editor
• The author ascertained that the clinical features of AH are
similar with the symptoms of sinus barotrauma. According
to author, the pressure changes during the landing phase
might be a key player in the pathophysiology of AH.
• According to author, sinus barotrauma could be prevented
by surgical or medical intervention.
2012, Purdy [14] N/A N/A N/A Editorial • The author postulated that sinus barotrauma might be
the main mechanism in the pathophysiology of AH.
• According to the author, the increasing number of case
reports on AH is important for the further research for
this headache that will allow future studies to examine
the mechanism and thereby develop specific therapeutic
strategies.
2012, Shevel [32] N/A N/A N/A Letter to the
editor
• The author stated that it does not seem plausible that
the changes in the barometric pressure should trigger
the AH-attack during the ascending or descending
phases. The pressure in the sinus is low during the whole
flight travel and will not be affected by the increasing
ambient pressure during the descending phase.
• The pressure in the cabin and the intra-sinus pressure is
the lowest during the whole flight travel. The pain is ex-
pected to occur during this phase, which is not the case.
2012, Mainardi et al. [6] 75 29 M/ 46 F 36.5 ± 10.2 Journal article • The majority of the patients developed a headache during
the landing. The headache lasted less than 30 min. In most
of the cases, the pain was described as jabbing, stabbing
and located in the fronto-orbital region. The intensity of
pain was severe and rated as 8.8/10.
• A subgroup, consisting 29 AH-patients, took medications.
Only 11 of the patients were completely headache-free
when they used ibuprofen, naproxen, aspirin and nasal
decongestant.
• A minority of the patients used non-pharmacological
methods such as Valsalva manoeuvre, pressure on pain
site chewing. These methods showed an unremarkable
efficacy.
• The authors did not think that the change in pressure is
the only trigger for the AH-attack. Other factors such as
environmental factors (aircraft speed, angle of ascent/
descent, maximum altitude) and anatomic factors (acquired
or congenital abnormalities of sinus outlet might contribute
to the development of AH.
2013, Mainardi et al. [33] 11 5 M/6 F 37 Conference
abstract
• All patients suffered from AH and experienced a similar
headache when they were descending a mountain by
car. Both headaches were described as a severe jabbing
pain in the unilateral fronto-temporal region and lasted
about 20 min.
• General and neurological examination, brain MRI, MRA,
and cranial CT-scan for sinuses showed normal findings.
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(Continued)
• The authors suggested that both headaches might share
a possible common pathophysiology mechanism as
both headaches are trigged by changes in the pressure.
2013, Mainardi et al. [34] 9 4 M/5 F 37 ± 12 Conference
abstract
• All AH-patients experienced a similar headache when
they were scuba diving. The headache pain started
shortly after the ascent.
• MRI, MRA and cranial CT-scan for sinuses showed normal
findings.
• The authors suggested that AH and headache attributed
to scuba diving might share a common pathophysiology
mechanism as both headaches are trigged by external
pressure.
2013, Mainardi et al. [3] N/A N/A N/A Journal article • The authors stated that AH might share a common
physiological mechanism with the situations when you
are descending from a mountain in car or diving as all
these conditions are trigged the changes in the pressure.
• Beside the pressure changes, other factors such as
environmental factors (aircraft speed, angle of ascent/
descent, maximum altitude) and anatomic factors
(acquired or congenital abnormalities of sinus outlet
might contribute to the development of AH.
• According to the authors, AH should be considered as a
formal headache by “International Headache Society”.
2013, Cherian et al. [35] 2 2 M 33 ± 1 Case reports • Both patients developed headache during the descent.
The pain was described as jabbing, stabbing and located
in the unilateral supraorbital region. The intensity of pain
was severe and rated as 9.5/10.
• MRI and CT showed normal findings. Only one patient
had a history of migraine without aura.
• The patients took oxymetazoline nasal drops in combination
with naproxen sodium which completely prevented the AH-
attacks.
2013, Nagatani [21] 2 1 M/1 F 37.5 ± 11.5 Case reports • Both patients developed a severe headache during the
descent. The headache lasted 30–40 min and the pain
was located in the fronto-orbital region.
• Medical history was not relevant for the female patient,
but male patient had had a past history of episodic
tension-type headache. Intracranial and paranasal CT
examinations showed normal findings.
• For the male patient, the headache only occurred when
he had mental stress or was suffering from a lack of sleep.
• NSAIDs were taken by both patients, but did not show
any relieving effect.
• The authors pointed out that the prevalence of AH
might be underestimated as many passengers, suffering
from AH, do not seek a doctor.
2015, Rogers et al. [18] 1 1 F 11 Case report • The patient experienced a severe headache during the
ascent. The pain was described as sharp, stabbing, throbbing
and located in the unilateral and frontal region. Every
headache episode was associated with dizziness, but there
were no additional accompanying symptoms.
• Medical history was significant for episodic migraine and
adenotonsillectomy only.
• Blood test, MRI and EEG showed normal findings.
• The authors stated that their data, in conjunction with
the reignition of AH by the International Headache
Society, contribute to the increasing evidence on AH.
2015, Mainardi et al. [36] 130 76 M/54 F N/A Conference
abstract
• The majority of the patients developed AH during the
landing phase. The pain was located in the frontal-orbital
region and lasted less than 30 min.
• The AH-attacks occurred more than 50% of the flight
travels in 35 patients and 23 patients experienced AH in
every flight travel.
• Prophylactic use of NSAIDs showed a relieving or preventing
effect in more than 50% of the cases.
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(Continued)
• The authors stated that these findings confirm the
stereotypical clinical features of an AH-attack.
2015, Mainardi et al. [37] 140 83 M/ 87 F N/A Conference
abstract
• The data from this publication are similar to the conference
abstract by Mainardi et al. [36].
2016, Hiraga et al. [23] N/A N/A N/A Case report • A 74-year old woman experienced a severe headache
during the descent. The headache met the criteria of
“International Classification of Headache Disorders 3 beta
version” [1] for AH.
• The headache pain continued for 48 h after landing.
• MRA showed segmental vasoconstriction of brain vessels
allowing the diagnosis reversible cerebral
vasoconstriction syndrome (RCVS).
• The authors suggested that RCVS may play a role in the
pathophysiology of AH.
2016, Mainardi et al. [22] N/A N/A N/A Editorial • The authors disagreed with the findings by Hiraga et al.
[23] and ascertain that the clinical features of reversible
cerebral vasoconstriction syndrome (RCVS) and AH are
not comparable. By instance, the duration of an AH-attack
does not exceed 30 min. The authors emphasized that
patients who are suffering a second phase headache after
an AH-attack should be investigated carefully in order to
rule out secondary pathology, including RCVS.
2016, Hiraga et al. [38] N/A N/A N/A Editorial • The authors agreed with Mainardi et al. [22] that AH and
reversible cerebral vasoconstriction syndrome (RCVS) are
two separated types of headache.
• However, they suggested that RCVS might be a potential
cause of AH in cases of second headaches arising after
the resolution of the triggering factors such as the
airplane descent. As a subgroup of AH sufferers do
experience a second phase headache after the AH-
attack, the authors believed that RCVS might be an
overlooked condition and the physicians should be
aware that airplane descent might be a trigger of RCVS.
2016, Mainardi et al. [20] 1 1 M 36 Case report • The patient experienced a headache when she was
descending from high altitude by car, called Mountain
Descending Headache (MDH). The clinical features of the
headache were identical to the stereotypical features of AH.
• The authors suggested that MDH and AH might share a
common pathophysiology mechanism as both headaches
are trigged by the imbalance between the pressure in the
sinuses and the changing environmental pressure.
2016, Zubero et al. [39] 1 1 F 34 Case report • The patient developed a severe predominant right
hemicranial headache with rhinorrhea and tearing
during take-off and landing.
• Medical history was not relevant. Neurological
examinations showed normal findings.
2016, Bui et al. [2] 21 9 M/12 F 39 ± 14 Journal article • All patients fulfilled the AH-criteria set by “International
Classification of Headache Disorders 3 beta version” [1].
• Seven patients suffered from migraine and 13 patients
suffered from High Altitude Headache.
• The statistical analysis indicated that High Altitude
Headache, but not migraine, might be a risk factor for AH.
• Five patients took medication, i.e. paracetamol and
triptans. These medications were effective to relieve and
prevent the headache pain.
• The authors supported the established hypothesis that
changes in the pressure might play a key role in the
mechanism of AH.
2017, Nath et al. [40] 2 2 M 45.5 ± 3.5 Case reports • The patients experienced a bilateral occipital and
parieto-occipital severe sharp shooting stabbing and
piercing headache during the landing. The headache
was associated with severe dizziness and lasted 40–
50 min after landing. Both patients rated the intensity of
pain as 8–9/10.
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• ENT, CT and MRI showed normal findings. Both patients
had no history of tension headache, migraine or cluster
headache.
• The authors ascertained that the duration of the
headache and the pain localization in the occipital and
parieto-occipital area are not in accordance with the AH-
criteria set by “International Classification of Headache
Disorders 3 beta version” [1].
2017, Bui et al. [25] 7 1 M/ 6 F 29.7 ± 9.6 Journal article • All patients fulfilled the AH-criteria set by “International
Classification of Headache Disorders 3 beta version” [1].
• A pressure chamber was used as an experimental model
to induce simulated AH in the patients. The clinical
features of the headache were in accordance with an
AH-attack in a real-time flight travel.
• Saliva samples, saturation pulse oxygen, blood pressure
and thermo imagining were collected and measured
before, during and after their simulated flight in the
pressure chamber.
• The data showed that the values for saturation pulse
oxygen, prostaglandin E2 and cortisol significant different
in AH-patients in comparison with the healthy participants.
AH Airplane headache also called headache attributed to airplane travel. CT computerized tomography. MRI brain magnetic resonance imagining.
MRA magnetic resonance angiography. ENT ear-nose-throat, EEG Electroencephalography, NSAIDs Non Steroidal Anti-Inflammatory Drugs
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may have a psychological impact on the passengers dur-
ing flight travels [12, 25]. The stress hormone cortisol
has also been shown to be significantly elevated in AH-
patients during a simulated flight when compared to
healthy subjects indicating a physiological response dur-
ing an AH-attack [25]. In addition, hypoxia has also
been considered to be one of the other factors that may
affect the development of AH [2, 25, 26].
AH treatment
Pharmacological treatment
According to the literature, 79 AH-patients have taken
medications in order to relieve the headache pain [2, 4,
6, 9, 11, 12, 16, 17, 19, 21, 26, 28, 35]. The medications
were naproxen (n = 24/79), triptans (n = 12/79), paraceta-
mol (n = 11/79), dipyrone (n = 7/79), ibuprofen (n = 6/
79), unspecified NSAIDs (n = 4/79), nasal decongestant
(n = 4/79), aspirin (n = 3/79), antibiotics (n = 2/79), anti-
histamine (n = 2/79), oxymetazoline (n = 1/79), and loxo-
profen (n = 1/79). Relieving effects of the medications
were reported by naproxen (n = 24/24), triptans (n = 9/
12), paracetamol (n = 1/11), ibuprofen (n = 3/6), nasal de-
congestant (n = 1/4), aspirin (n = 1/3), antibiotics (n = 1/
2), antihistamine (n = 2/2), and oxymetazoline (n = 1/1)
[2, 6, 9, 11, 16, 17, 19, 26, 28, 35].
Non-pharmacological treatment
A small group of AH-patients (n = 35) has used self-
administered maneuvers such as pressure on the headache
pain site (n = 19/35), Valsalva maneuver (n = 11/35),
relaxation methods (n = 3/35), chewing (n = 1/35), and
extension of the ear lobes (n = 1/35) [6]. The maneuvershad shown varying effects since only seven patients expe-
rienced a reduction in the pain intensity [6].
Discussion
Literature search
In this systematic review, 39 articles were included. The
authors decided to include all types of articles as the
literature within AH is very limited. Therefore, the main
purpose was to present and discuss the current evidence on
diagnosis, pathophysiology, and treatment of AH. However,
a restriction was made in the literature search strategy
where only English articles were included. Articles that
have not been indexed in PubMed, Scopus and Embase,
may have not been included in this review. Despite of this,
our systematic review presents 275 AH-patients, which,
together give a stereotypical clinical picture of AH.
AH diagnosis
The cumulative analysis in this review revealed that 127
females (46%) and 148 males (54%) have suffered from
AH (275 patients in total). At present, it is difficult to
conclude whether gender affects the development of
AH. By instance, there was a predominance of males in
few studies [4, 6, 26], whereas there was a predominance
of females in the study by Bui et al. [2]. Gender differ-
ence in some primary headaches has been documented
[41, 42], and if similar difference is identified in AH, it
will provide knowledge of which particular gender is
more susceptible to AH. The mean diagnosis age for AH
was 28.7 ± 4.8 years (n = 275/275), while the age at first
AH-attack was 26.4 ± 3.8 years (reported by 163/275 pa-
tients). These data may indicate that the diagnosis age of
AH and the first AH-attack may occur in a relatively
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ation on association of age with AH. This needs fur-
ther investigation to identify whether it is related to
pathophysiology of AH or demographic characteristics
of travelers.
The stereotypical clinical symptom of AH is an intense
unilateral pain locating in the fronto-orbital region. The
pain is very severe and is often described as 8–10 on a
pain scale from 0 to 10, where 0 is no pain and 10 is the
worst imaginable pain [2, 4, 6, 9, 25, 35, 40]. The pain
disappears within 30 min in most cases, where it seems
that the AH duration might correspond to the duration
of take-off and landing. However, there is a smaller
group of AH passengers who experience a second-phase
headache, which is a mild headache that may last hours
to days; but, it may not be considered as a direct
continuation of the intense headache that occurs within
the airplane.
Onset of AH was found mostly during the descending
phase in 210 patients (n = 210/275), followed by ascending
phase in 33 patients (n = 33/275) [2, 4, 6, 7, 9, 11, 15–17,
19, 21, 25–28, 35–37, 39, 40], and only 18 patients
(n = 18/275) were found to report it both during descend-
ing and ascending phase [2, 4, 5, 7, 11, 13, 26]. Based on
the findings, AH was found to occur in 138 patients
(n = 138/275) [5, 15, 17, 19, 28, 35–37] since their first
flight experience.
AH is experienced without accompanying symptoms
in almost all cases; but, there are few cases that cannot
be considered as part of the stereotypical clinical symp-
toms of AH [13, 18]. In the current literature, there are
54 patients suffering from migraine [2, 4, 6, 7, 18].
Although there are many who suffer from migraine, it
does not indicate that there is a direct link between
migraine and AH [2]. In addition, these migraine pa-
tients have reported that they experienced AH and not
migraine attacks (2,4,6,7,18). Furthermore, 22 patients
suffering from tension type headache, did also report a
pure AH-attack and not a tension type headache-attack
[6, 12, 21]. In relation to sinus infections, only few
cases have been reported, where there was an active
sinus infection in the passengers who experienced AH
[16]. This indicates that AH is a separate headache that
is not associated with other headaches and conditions;
but, it is currently unclear whether certain headaches
or conditions (such as stress and anxiety) are potential
risk factors for developing AH.
In 2013, AH was formally classified by IHS, where
diagnostic criteria for AH were established [1]. This
makes it possible for future studies to use the diagnostic
criteria for harmonizing the research within this field
(e.g. Bui et al. [2, 25]). It will also make it easier for doc-
tors to diagnose AH at clinic as the criteria can be used
identically.AH pathophysiology
Berilgen et al. [7] were the first to suggest “sinus
barotrauma” as a potential mechanism underlying AH,
which has been a key element in the subsequent discus-
sion for AH mechanisms [2–5, 9–14, 18–21, 24–27, 32,
35, 39, 40]. It is well known that imbalance between
atmospheric pressure changes and pressure inside the
sinuses can cause tissue damage [43–45]. This means,
for example, that the pressure in the sinuses is lower
than the cabin pressure during the landing [6, 26]. At
take-off, the cabin pressure is lower than the sinuses [6,
26]. It has also been shown that the cabin pressure
changes during a flight travel, where the cabin pressure
will decrease with around by 8 hPa for every 300 m the
airplane increases in altitude [46]. The normal altitude
for airplanes is 2500 m with a stabilized cabin pressure
at 846 hPa [46].
Berilgen et al. [7] suggest that the first-degree sinus
barotrauma is the key mechanism underlying AH. During
the first-degree sinus barotrauma, nerve endings in the
ethmoid sinuses, which are invaded by the trigeminal
nerve [47], are affected. This causes pain in the fronto-
orbital region [7, 48], which explains that the pain is
mainly experienced in the orbital region [2, 4–13, 15–18,
21, 25–28, 35]. The proposal of first-degree sinus baro-
trauma may be reasonable as it is explained by the fact
that neurological examinations, such as CT, MRI, MRA
and ENT, have shown normal sinus conditions in several
studies [5, 7–13, 15, 17, 18, 21, 26, 35]. However, few
studies have shown cases of thickened nasal mucosa
among 2 AH-patients with allergy and chronic rhinosi-
nusitis [16, 19]. The patient with allergy was treated
with antihistamines and subsequently experienced
headache-free flight travels [16]. Data from these stud-
ies indicate that thickened nasal mucosa resulted from
the allergy and chronic rhinosinusitis and not as a result
of the flight travels. Coutinho et al. [17] suggest that MRI
should be used to rule out other conditions including
sinus barotrauma. This indicates that Coutinho et al. [17]
have not taken into account the degrees of sinus baro-
trauma as those are only the second-degree and third-
degree that show thickened nasal mucosa [45]. Relative to
the pain of AH, the pain usually disappears within 30 min
[2, 5–13, 15–19, 21, 25–27, 35], which is consistent with
the short-term pain at the first-degree sinus barotraume
[45]. However, neurological examinations were not per-
formed on all the presented 275 AH-patients in this re-
view and this should be considered in the future for
proper diagnosis of AH at clinic.
It is still unknown which specific substances play a
role in the mechanism of AH. Bui et al. have speculated
that vasodilation may occur in the cerebral arteries dur-
ing an AH-attack [25]. One of the substances investi-
gated in that study was PGE2, where PGE2 levels were
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pared with healthy subjects during a simulated flight
in a pressure chamber [25]. Wienecke et al. have
shown that PGE2 can induce vasodilation in the
cerebral arteries and headache in healthy subjects by
infusion of PGE2 [49]. Authors suggested that PGE2-
induced headache might be due to activation and
sensitization of cranial perivascular sensory afferents
[49]. As local inflammation may occur in the sinuses
during an AH-attack [2–7, 9–14, 18–21, 24–27, 32,
35, 39, 40], it may be reasonable to consider that
PGE2 increases as a consequence of this inflammatory
condition [25]. This makes PGE2 an interesting
potential biomarker for AH and infusion of PGE2 in
AH-patients in future studies may provide knowledge
whether PGE2 play a role in the AH mechanism.
The theoretical mechanism of AH is mainly based on
barotrauma [2–7, 9–14, 18–21, 24–27, 32, 35, 39, 40]
and possibly vasodilation in the cerebral arteries [25]. A
study by Hiraga et al. [23] considers the opposite. The
authors point out that vasoconstriction may be the cause
of AH. The female patient in their study experienced a
headache, which lasted for several hours and days when
they performed a neurological examination and contrac-
tion of her cerebral arteries was seen. Mainardi et al. [22],
however, proposed that patient’s symptoms do not match
with the diagnostic criteria for AH and hence it is unclear
whether vasoconstriction in the cerebral arteries can be a
cause or a consequence of AH. For future studies, it would
be valuable to use imaging techniques during a real or
simulated flight travel to investigate whether vasoconstric-
tion or vasodilation occurs in the cerebral arteries during
an AH-attack.
It has been shown that cortisol levels were significantly
higher before and during a simulated flight in a small
group of AH-patients compared with a healthy matched
group tested in a pressure chamber [25]. Some AH-
patients reported that they felt stressed and had anxiety
during the simulated flight [25]. In addition, Kararizou
et al. [12] has also presented an AH-patient with anx-
iety. This might indicate that psychological aspects can
also contribute in AH [12, 25]. However, flight passen-
gers frequently present stress and anxiety in dealing
with the flight and in most of cases they do not com-
plain of AH. On the contrary, patients who do not have
any negative emotional impact may start to present
anxiety and stress when they experience AH. Therefore,
stress and anxiety could be considered as a conse-
quence of the fearing to develop AH instead of being
one of principal pathogenetic mechanisms of AH. If
anxiety and stress did have a predominant role in the
pathogenesis of AH, then it should be expected that
AH may occur in almost every flight, which is not
the case.It may be difficult to run experiments during a real-time
flight travel both from practical points and also safety
issues. However, an experimental model might be a rea-
sonable alternative that can be used to induce AH, which
allows investigating more physiological aspects of AH. Bui
et al. [25] used a pressure chamber to study AH under
controlled experimental conditions. In the chamber, pres-
sure changes, which correspond to the changes during
take-off and landing, are applied. This study presented
occurrence of AH during simulated flight in those who
suffer from this condition but not healthy controls [25].
The clinical symptoms of the simulated AH were found
similar to the symptoms of the real-time AH-attacks [25].
This indicated that it is possible to use the pressure cham-
ber as a platform experimental model to induce AH and
to investigate AH under fully controlled conditions.
Furthermore, it can also be used to investigate whether
AH is associated with risk factors or comorbidities in fu-
ture studies.
AH treatment
There is no specific treatment plan for AH, that might be
due to the fact that this headache is considered short last-
ing and terminated after the flight travel is over. However,
evidences in the literature demonstrate that some passen-
gers suffering from AH, have been required to take medi-
cations to subside the headache. This systematic review,
only focused on pharmacological treatment, although there
have been cases of non-pharmacological treatments [6].
Several flight passengers have been self-medicated in
order to relieve AH, where only ibuprofen, naproxen,
and triptans have been found the most effective [2, 6, 9,
11, 16, 17, 26, 35]. Only Berilgen et al. [26] have pre-
scribed naproxen to their 21 subjects and all subjects
experienced no headache after intake of naproxen before
the start of their flights. Today, the effects of ibuprofen,
naproxen, and triptans are based on the patient’s own
narratives [2, 6, 9, 11, 16, 17, 26, 35]. Therefore, future
studies seem necessary to provide a clear guideline as
whether or not medications are actually needed and which
patient will get the best benefit. Since most studies are
based on case series and case reports, it is reasonable to
perform future randomized controlled trials (RCTs) on
pharmacological treatments of AH. Setting up a double
blind RCT, where a control group is given placebo, and
the other group, medication (ibuprofen, naproxen or
triptans), can reveal the actual effect of medications
on AH.
Based on the finding of this review, 6 flight passengers
have taken ibuprofen, where 4 of those have experienced
a relieving effect [6, 9, 16]. For the naproxen, 24 flight
passengers have taken this medication with all experien-
cing a relieving effect [17, 26, 35]. If PGE2 has a central
role in the mechanism of AH, then ibuprofen and
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inhibit COX, reduce elevated levels of PGE2 during an
AH-attack, and can abort headaches [25, 50].
Ipekdal et al. [11] performed a study in 2011 and
included 5 patients who took triptans 30 min before
flight travels and this prevented development of AH
completely [11]. Cumulative findings of this systematic
review showed that 12 patients have taken triptans in
order to relieve AH [2, 4, 11]. Triptans are a class of
drugs developed for abortion of migraine headaches [11,
51–53]. In relation to AH, Ipekdal et al. [11] have sug-
gested that triptans may cause vasospasms during an
AH-attack and thereby prevent it. There is, however,
no evidence to present a mechanism-based explan-
ation for use of triptans for AH.
Calcitonin gene-related peptide (CGRP) and vasoactive
intestinal peptide (VIP) are believed to play a role in
vasodilation in the cerebral arteries leading to develop-
ment of migraine attacks [54]. Bellamy et al. have shown
that CGRP and VIP levels are significantly reduced when
patients take triptans during a migraine attack [54],
which is associated with a significant relief of headache
[54]. Future studies are required to investigate whether
CGRP and VIP also play a role in development of AH. If
AH is a result of vasodilation in the cerebral arteries,
elevated levels of CGRP and VIP might be seen in AH
and triptans that have shown some benefits for AH may
act on these headache biomarkers.
The frequencies of AH-attacks are relatively high; 42
flight passengers experience AH in every flight travels and
39 flight passengers experience AH in more than 50% of
the flight travels [4–6, 12, 19, 21, 27, 39, 40]. For the rest
of 194 AH-patients presented in this systematic review it
is not known how often AH occurs. Clinical trials, such as
RCTs, seem necessary for better understanding of AH and
the value of considering strategic plans for treatment or
prevention of AH.Conclusions
Based on this systematic review, it is now evident that
further studies are required to investigate AH systematic-
ally. Investigations may clarify unknown aspects of AH
diagnosis that can be taken in updates of AH classification
by IHS. Future experimental studies are also essential to
further investigate proposed mechanisms underlying
AH; barotrauma and vasodilation in the cerebral arter-
ies, and also to investigate the biological effects of most
used medications, ibuprofen, naproxen and triptans for
alleviating of AH-attacks. These studies would advance
our understanding of AH pathogenesis and value of
treatment options that are not yet established. This
would subsequently help millions of passengers suffer-
ing from this condition.Authors’ contributions
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